68Ga-P15-041

N/A

Report date: 2025/09/12 15:57:42
NME

Base Information

Drug Name68Ga-P15-041
Drug Alias Name[68Ga]Ga-HBED-CC-bisphosphonate
ClassificationSmall moleculesDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionEmission-computed tomography enhancersPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsBone metastasesProstatic NeoplasmsBone Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFive Eleven Pharma IncUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Fujian Medical UniversityFive Eleven Pharma Inc
Inactive CompaniesN/A
Active IndicationsBone metastasesProstatic NeoplasmsBone Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A